Latest filing published 17 Sept 2024 for C4 Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Stewart Fisher: trading record in brief
This profile gathers the share dealings of Stewart Fisher in C4 Therapeutics, Inc., where the filings describe the role as senior executive. We count 23 filings; the first trade dates from 11 December 2020 and the latest from 16 September 2024.
On the market, this insider has only sold: 3 sales, €3.2M in total. Other entries cover 7 share grants and 13 option exercises.
The latest filing, published on 17 September 2024, reports a share grant of €3,777 in C4 Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stewart Fisher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,250 sharesCommon StockSEC:0001662579-24-000081:0
- 2,255 shares@ US$6.530.3% of flowCommon StockSEC:0001662579-24-000016:0
- 2,250 sharesCommon StockSEC:0001662579-23-000082:0
- 26,000 shares0Common StockSEC:0001662579-23-000039:0
- 3,750 sharesCommon StockSEC:0001662579-23-000018:0
- 1,102 shares@ US$7.010.3% of flowCommon StockSEC:0001209191-22-036715:0
- 3,750 sharesCommon StockSEC:0001209191-22-032511:0
- 2,156 shares@ US$3.710.3% of flowCommon StockSEC:0001209191-22-024228:0
- 2,373 shares@ US$2.110.2% of flowCommon StockSEC:0001209191-21-069036:0
- 17,057 shares@ US$45.014525.1% of flowCommon StockSEC:0001209191-21-050055:0
- 50,211 shares@ US$45.002773.7% of flowCommon StockSEC:0001209191-21-049116:0
11 of 11 declarations
